Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 44 M47 M50 M46 M50 M50 M 196 M Research & development —————— — Operating income -22 M4 M13 M10 M14 M17 M 54 M Non-Operating Income, Total -21 M-5 M0-4 M-3 M1 M -6 M Interest expense, net of interest capitalized 26 M39 M37 M39 M40 M35 M 151 M Non-Operating Income, excl. Interest Expenses -26 M-39 M-37 M-39 M-40 M-35 M -151 M Unusual income/expense -21 M-5 M0-4 M-3 M1 M -6 M Pretax income -69 M-40 M-24 M-33 M-29 M-17 M -103 M Equity in earnings —————— — Taxes -9 M1 M-6 M7 M5 M1 M 7 M Non-controlling/minority interest —————— — After tax other income/expense -32 M-5 M-8 M-10 M-9 M0 -27 M Net income before discontinued operations -60 M-41 M-18 M-40 M-34 M-18 M -110 M Discontinued operations —————— — Net income -60 M-41 M-18 M-40 M-34 M-18 M -110 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders -60 M-41 M-18 M-40 M-34 M-18 M -110 M Basic earnings per share (Basic EPS) -1.69-1.15-0.51-1.12-0.95-0.5 -3.08 Diluted earnings per share (Diluted EPS) -1.69-1.15-0.51-1.12-0.95-0.5 -3.08 Average basic shares outstanding 35.4 M35.6 M35.6 M35.5 M35.7 M35.9 M — Diluted shares outstanding 35.4 M35.6 M35.6 M35.5 M35.7 M35.9 M — EBITDA -138 M19 M71 M—-553 M-560 M — EBIT -191 M4 M13 M—-602 M-611 M — Cost of revenue 631 M736 M749 M751 M695 M701 M 2.9 B Other cost of goods sold —————— — Depreciation & amortization (cash flow) 53 M58 M58 M37 M49 M51 M 195 M